Clinical impact of depression and anxiety in patients with non-cystic fibrosis bronchiectasis

被引:3
|
作者
Bekir, Melahat [1 ]
Kocakaya, Derya [2 ]
Balcan, Baran [2 ]
Olgun Yildizeli, Sehnaz [2 ]
Eryuksel, Emel [2 ]
Ceyhan, Berrin [2 ]
机构
[1] Okan Univ, Tip Fak, Gogus Hastaliklari Anabilim Dali, Istanbul, Turkey
[2] Marmara Univ, Tip Fak, Gogus Hastaliklari Anabilim Dali, Istanbul, Turkey
来源
关键词
Depression; anxiety; bronchiectasis; SEVERITY; STANDARDIZATION; OUTPATIENTS;
D O I
10.5578/tt.69348
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Bronchiectasis is a chronic suppurative disease characterized by abnormal bronchial dilatation. The nature of bronchiectasis may have negative impact on psychological status, however it is poorly studied in relation to clinical indices, particularly the severity of disease. Primary aim of this study is to detect depression and anxiety in patients with non-cystic fibrosis bronchiectasis and to evaluate its relationship with disease severity indexes. Materials and Methods: Ninety (male/female= 37/53; median age 45 years) stable non-cystic fibrosis bronchiectatic adult patients were enrolled into this study. Dyspnea scores, number of exacerbations and hospital admissions within the last year, body-mass index, pulmonary function tests, sputum cultures, bronchiectasis disease severity indexes (BSI and FACED) were assessed. Anxiety and depression were evaluated by using the Turkish version of the hospital anxiety and depression scale questionaire. Results: Anxiety was diagnosed in 30% of patients and depression was diagnosed in 41% of the participants. Female participants had significantly higher rates of depression (55% vs. 22%; p= 0.002). Exacerbation rates within the last year were higher among the subjects with anxiety, moreover, patients with depression had shorter duration of disease. 851 and FACED severity indexes increased with longer duration of disease (5.6 +/- 5.0 yrs in mild group vs. 10.1 +/- 9.2 yrs in moderate-to-severe group, p= 0.035 and 5.7 +/- 5.4 yrs in mild group vs. 12.1 +/- 9.7 yrs in moderate-to-severe group, p= 0.001, respectively), however, anxiety and depression were not related with BSI and FACED severity indexes. Conclusion: Patients with non-cystic fibrosis bronchiectasis have an increased risk for depression and anxiety. Duration of disease and higher exacerbation rate are related with psychological status and indexes increased with longer duration of disease. Lady detection and taking the necessary measures to improve the psychological state is necessary for the overall management of these patients.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 50 条
  • [21] Non-cystic fibrosis bronchiectasis in children
    Gursoy, Tugba Ramasli
    Eyuboglu, Tugba Sismanlar
    Aslan, Ayse Tana
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [22] Non-Cystic Fibrosis Bronchiectasis In Patients With Hematologic Malignancy
    Chen, L. W.
    Karkowsky, W. B.
    Montner, S.
    McShane, P. J.
    White, S. R.
    Strek, M. E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [23] Treatment of Non-Cystic Fibrosis Bronchiectasis
    Martinez Garcia, Miguel Angel
    Maiz Carro, Luis
    Catalan Serra, Pablo
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (12): : 599 - 609
  • [24] Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
    Bar-Yoseph, Ronen
    Ilivitzki, Anat
    Gur, Michal
    Mainzer, Gur
    Hakim, Fahed
    Livnat, Galit
    Schnapp, Zeev
    Shalloufeh, George George
    Zucker-Toledano, Merav
    Subar, Yael
    Bentur, Lea
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [25] Statins for non-cystic fibrosis bronchiectasis
    Feldman, Charles
    [J]. LANCET RESPIRATORY MEDICINE, 2014, 2 (06): : 431 - 432
  • [26] Non-cystic fibrosis bronchiectasis Response
    Murray, Maeve P.
    Hill, Adam T.
    [J]. CLINICAL MEDICINE, 2009, 9 (04) : 402 - 402
  • [27] Exacerbations in non-cystic fibrosis bronchiectasis
    Sahnoun, Imen
    Racil, Hajer
    Hafaied, Safa
    Bacha, Saoussen
    Rouhou, Sana Cheikh
    Chawech, Newel
    Mhiri, Emna
    Chabbou, Abdellatif
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [28] Management of Non-Cystic Fibrosis Bronchiectasis
    Dull, Stacey K.
    Havlat, Brooke D.
    Sanley, Michael J.
    Malesker, Mark A.
    [J]. CONSULTANT PHARMACIST, 2018, 33 (11): : 658 - 666
  • [29] Nontuberculous Mycobacteria in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis
    Park, In Kwon
    Olivier, Kenneth N.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (02) : 217 - 224
  • [30] Impact Of Inhaler Use On Development Of Hemoptysis In Patients With Non-Cystic Fibrosis Bronchiectasis
    Lee, J-K
    Lee, J.
    Park, Y.
    Lee, C.
    Lee, S-M
    Yim, J-J
    Yoo, C-G
    Kim, Y.
    Han, S.
    Park, S.
    Heo, E.
    Chung, H.
    Kim, D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187